TP53 and acute myeloid leukemia: The presence of mutations such as TP53 and ASXL1 is recognized as a particularly poor prognosis, while CBF-AML with chromosomal abnormalities such as t(8;21)(q22;q22) are classified as having a favorable prognosis [9,10,11].